Shandong Weigao Orthopaedic Device Co., Ltd Stock price

Equities

688161

CNE1000050W9

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
25.55 CNY +1.47% Intraday chart for Shandong Weigao Orthopaedic Device Co., Ltd -13.45% -38.36%
Sales 2024 * 2.92B 403M Sales 2025 * 3.61B 499M Capitalization 10.22B 1.41B
Net income 2024 * 760M 105M Net income 2025 * 940M 130M EV / Sales 2024 * 3.51 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.83 x
P/E ratio 2024 *
13.5 x
P/E ratio 2025 *
10.9 x
Employees 2,047
Yield 2024 *
2.23%
Yield 2025 *
2.74%
Free-Float 10.54%
More Fundamentals * Assessed data
Dynamic Chart
Weigao Orthopaedic Device Names Chairman MT
Weigao Orthopaedic Device's Chairman Resigns MT
Weigao Orthopaedic Device's Profit Slumps 81.5% in 2023 MT
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Shandong Weigao Orthopaedic Device Co., Ltd's Equity Buyback Plan announced on August 30, 2023. CI
Shandong Weigao Orthopaedic Device Co., Ltd(XSSC:688161) added to S&P Global BMI Index CI
Shandong Weigao Orthopaedic Device Co., Ltd announces an Equity Buyback for CNY 120 million worth of its shares. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Shandong Weigao Orthopaedic Device Co., Ltd authorizes a Buyback Plan. CI
Shandong Weigao Orthopaedic Device Co., Ltd's Board intends to launch an Equity Buyback Plan. CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Shandong Weigao Orthopaedic Device Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Shandong Weigao Orthopaedic Device's 2022 Profit Down 20.8% MT
More news
1 day+1.47%
1 week-13.45%
Current month-22.10%
1 month-23.04%
3 months-35.00%
6 months-37.41%
Current year-38.36%
More quotes
1 week
25.01
Extreme 25.01
29.18
1 month
25.01
Extreme 25.01
33.21
Current year
24.50
Extreme 24.5
41.52
1 year
24.50
Extreme 24.5
62.40
3 years
24.50
Extreme 24.5
124.80
5 years
24.50
Extreme 24.5
124.80
10 years
24.50
Extreme 24.5
124.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 17-12-31
Director of Finance/CFO 53 23-10-26
Chief Tech/Sci/R&D Officer 41 14-01-31
Members of the board TitleAgeSince
Director/Board Member 62 23-03-16
Director/Board Member 50 20-03-25
Chief Executive Officer 50 17-12-31
More insiders
Date Price Change Volume
24-03-27 25.55 +1.47% 982 069
24-03-27 25.18 -2.25% 1,080,717
24-03-26 25.76 -0.96% 1,023,347
24-03-25 26.01 -4.45% 1,335,417
24-03-22 27.22 -5.39% 2,041,449

End-of-day quote Shanghai S.E., March 27, 2024

More quotes
Shandong Weigao Orthopaedic Device Co Ltd is a China-based company mainly engaged in the research and development, production and sales of orthopedic medical devices. The Company's products include orthopedic implanted medical devices and orthopedic surgical instruments. The Company's products cover various orthopedic implanted medical device fields such as spine, trauma, joint and sports medicine, among others. The Company mainly conducts its businesses within domestic market.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
25.55
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Shandong Weigao Orthopaedic Device Co., Ltd - Shanghai S.E.